Regeneron Pharmaceuticals
REGN
$818.43
Share price
-1.59%
Change (1 day)
16.22%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Cash on Hand
Cash on Hand as of June 2023 : $8.92 B
According to Regeneron Pharmaceuticals's latest financial reports the company has $8.92 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Regeneron Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $14.33 B | 14.37% |
| 2021-12-31 | $12.53 B | 86.43% |
| 2020-12-31 | $6.72 B | 3.89% |
| 2019-12-31 | $6.47 B | 41.76% |
| 2018-12-31 | $4.56 B | 57.62% |
| 2017-12-31 | $2.89 B | 52.19% |
| 2016-12-31 | $1.90 B | 13.45% |
| 2015-12-31 | $1.67 B | 23.28% |
| 2014-12-31 | $1.36 B | 25.53% |
| 2013-12-31 | $1.08 B | 84.49% |
| 2012-12-31 | $0.58 B | 11.49% |
| 2011-12-31 | $0.52 B | -15.95% |
| 2010-12-31 | $0.62 B | 83.68% |
| 2009-12-31 | $0.34 B | -28.1% |
| 2008-12-31 | $0.47 B | -38.06% |
| 2007-12-31 | $0.76 B | 66.88% |
| 2006-12-31 | $0.45 B | 53.84% |
| 2005-12-31 | $0.29 B | 0.87% |
| 2004-12-31 | $0.29 B | 0.75% |
| 2003-12-31 | $0.29 B | 11.16% |
| 2002-12-31 | $0.26 B | -31.37% |
| 2001-12-31 | $0.38 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.61 B | 175.69% | 🇺🇸 USA |
 Novartis NVS | $11.17 B | 25.16% | 🇨🇭 Switzerland |
 Amgen AMGN | $34.24 B | 283.62% | 🇺🇸 USA |
 Sanofi SNY | $8.68 B | -2.70% | 🇫🇷 France |
 Biogen BIIB | $6.07 B | -31.92% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.05 B | -76.95% | 🇺🇸 USA |